SBI Securities’s Sanara MedTech SMTI Stock Holding History

SBI Securities’s Portfolio SMTI Stock Details SMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2	Closed	-$63	–	4198
2025 Q3	$63	Buy	+2	New	+$60	﹤0.01%	3645

Other funds holding SMTI

Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SWM

Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SBI Securities's SMTI Position: Q4 2025 in Review

SBI Securities sold out of Sanara MedTech (SMTI) in Q4 2025, closing a stake of 2 shares — an estimated $63 sold.

SBI Securities first reported a position in SMTI in Q3 2025 and held it in 1 quarter. The position peaked at $63 in Q3 2025. 53 funds tracked by Wall St. Rank hold SMTI as of Q4 2025.

SBI Securities reported no remaining Sanara MedTech position as of Q4 2025 after selling out during the quarter.
SBI Securities sold 2 Sanara MedTech shares in Q4 2025, an estimated $63.
SBI Securities first reported a position in Sanara MedTech in Q3 2025 and held it in 1 quarter.
SBI Securities's Sanara MedTech position peaked at $63 in Q3 2025.
53 funds tracked by Wall St. Rank held Sanara MedTech as of Q4 2025.

Based on SBI Securities's 13F filing for Q4 2025, filed 3 Feb 2026.